FTSE Mondo Visione Exchanges Index:
News Centre
-
CBOT March 10, 2005 Treasury Conversion Factors
Date 10/03/2005
-
CBOT Commodity And Financial Futures Contracts Set New Open Interest Records - CBOT Precious Metals Complex Open Interest Climbs To New High
Date 10/03/2005
The Chicago Board of Trade (CBOT) announced today that on Wednesday, March 9, open interest in several of the Exchange’s Commodity and Financial futures contracts rose to new all-time highs.
-
CBOE Futures Exchange Sets New Single-Day Trading Record
Date 10/03/2005
The CBOE Futures Exchange, LLC (CFE) announced that today's trading volume set a new single-day record with reported volume of 2,628 futures contracts, eclipsing the previous high of 2,132 contracts traded on February 3, 2005. Total open interest at today's open stood at 12,178 contracts.
-
Winnipeg Commodity Exchange Canola Futures Prices Continue Downward Trend
Date 09/03/2005
Canola futures prices at the Winnipeg Commodity Exchange continued their downward trend during the month of Janu-ary.The March 2005 contract closed the month at $252.20 per metric tonne,down $20.40 from December 31.The nearby contract has not traded this low since November 2000.Slow demand and the large supply of canola in Western Canada and large supplies of canola/ rapeseed and other oil crops worldwide have continued to be a bearish influence.On February 2nd,Statistics Canada reported Canadia
-
Tokyo Stock Exchange Monthly Quotations – February 2005
Date 09/03/2005
Monthly Quotations will be available on the 7th working day of the following month. * Some items are written in both Japanese and English (Japanese might be unreadable). Click here for full details.
-
Testimony Of Martin Doyle, President, OneChicago LLC Hearing On CFTC Reauthorization, March 9, 2005 Before The House Agriculture Committee Subcommittee On General Farm Commodities And Risk Management
Date 09/03/2005
Marty Doyle, President of OneChicago, testified before a House subcommittee today on the reauthorization of the Commodity Futures Modernization Act of 2000 (CFMA), which lifted the 20-year ban and authorized the trading of security futures.
-
Standard & Poor's Announces Changes To U.S. Investable Weight Factors And Final Float Transition Schedule
Date 09/03/2005
Standard & Poor's today publishes revised investable weight factors for three companies in the S&P 500 and one company in the S&P SmallCap 600, and provides a detailed schedule of changes surrounding the first step in moving its U.S. indices to float adjustment.
-
Spencer Barasch, Head Of Enforcement For The SEC's Fort Worth Office, To Leave The Commission
Date 09/03/2005
The SEC announced today that Spencer C. Barasch will leave the Commission in April to become a partner in the Dallas office of the law firm of Andrews Kurth LLP. For the past seven years, as the senior enforcement official in the Commission's Fort Worth Office, Barasch has led the Commission's enforcement program in a four state area of the Southwest. Before that, he held various other positions in the Commission, including Assistant Director in the Commission's Southeast Office in Miami, Fla.
-
Securities Industry Association: Keep The ‘Self’ In Self-Regulation - SIA Offers Recommendations For Addressing Shortcomings Without Losing Key Benefits Of Self-Regulation
Date 09/03/2005
The Securities Industry Association today called on the Securities and Exchange Commission to focus its efforts at self-regulatory reform on preserving the key benefits of self-regulation, while addressing its shortcomings. In a comment letter filed today on the SEC’s SRO Governance and Transparency Proposal and SRO Concept Release, SIA made several specific recommendations for enhancing and improving self-regulation.
-
SEC Charges Two Friends Of Former ImClone CEO Samuel Waksal With Insider Trading
Date 09/03/2005
The Securities and Exchange Commission today charged Zvi Fuks and Sabina Ben-Yehuda, two friends of the former CEO of ImClone Systems Inc., Samuel Waksal, with insider trading in ImClone securities in December 2001. The Commission charged that Ben-Yehuda and Fuks sold ImClone stock after receiving an illegal tip from Waksal just before the FDA denied approval of ImClone's cancer treatment drug.
- First
- Previous
- 18329
- 18330
- 18331
- 18332
- 18333
- 18334
- 18335
- 18336
- 18337
- 18338
- 18339
- 18340
- 18341
- 18342
- 18343
- 18344
- 18345
- Next
- Last